Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18187415 | 0.63 | LMNA (0.32) | LMNA | |
| SCHEMBL25823159 | 0.63 | LMNA (0.32) | LMNA | |
| SCHEMBL3898748 | 0.61 | LMNA (0.35) | LMNA | |
| SCHEMBL5952317 | 0.61 | LMNA (0.35) | LMNA | |
| SCHEMBL23502352 | 0.57 | — | — | |
| SCHEMBL27831045 | 0.57 | LMNA (0.32) | LMNA | |
| Ether SCHEMBL7738174 | 0.57 | LMNA (0.44) | LMNA | |
| SCHEMBL3890570 | 0.57 | ALDH1A1 (0.32) | — | |
| SCHEMBL50777 | 0.57 | ALDH1A1 (0.32) | — | |
| SCHEMBL27913833 | 0.57 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-20210352945-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF | HERCULES CAPITAL, INC. | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | FUT5, FUT6, OSTC | LMNA 3367/4885 |
| US-20210352945-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF | OSTC, FUT5, FUT6 | LMNA 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.